AI, Privacy, & Genomics: The Next Era of Drug Design

in ai •  4 years ago 

2020 has shed light on the unacknowledged void present in the drug manufacturing system despite the technological preferment and reduced period between the proposed drug and its availability on the shelf. This report studies recent developments in both Artificial Intelligence (AI) and drug R&D. In addition to this, it discusses the crucial role AI will play and how its relation to available genetic data can shape how the industry works while keeping in check the importance of AI privacy and how multiparty access will deal with it. To find out more about the privacy issues and solutions involved in AI and genomics, here is the link to the full report: https://www.dgen.org/ai-privacy-and-genomics

ai covid19 genetics genomes blockchain
4 years ago by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
    0
    Authors get paid when people like you upvote their post.
    If you enjoyed what you read here, create your account today and start earning FREE STEEM!